← Leaderboards
Laura Andres-Martin
New York Stem Cell Foundation
$626,400
Attributed
$626,400
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $234.9K · FY2019–21$250K$187.5K$125K$62.5K$0
'19
'20
'21
Funding mix
By agency
NIH$626,400 · 1
By mechanism
R21$626,400 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Accounting”
- Martha Hering · Westat, Inc.$57,098,843
- John Hobbs · Suny At Stony Brook$41,239,084
- Christopher Bee · Suny At Stony Brook$41,239,084
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Pamela Winer Goldberg · Medical Device Innovation Consortium$28,780,000
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,689,457
Research focus
AccountingAdoptionAdult Stem CellAffectAnticancer ResearchAntineoplastic AgentsAutomationBaseBasic ScienceBiobankBiological ModelsCancer CellCancer EtiologyCancer PatientCancer TypeCell Culture TechniquesCell LineCellsCessation Of LifeChemotherapeutic AgentChemotherapyClinically RelevantClinical Research3-Dimensional
Grant awards (3)
Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections$195,750
R21 · FY2021 · CA · contact PI
Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections$234,900
R21 · FY2020 · CA · contact PI
Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections$195,750
R21 · FY2019 · CA · contact PI